[Research progress on non-surgical treatment of vestibular schwannomas]

Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2022 Dec;36(12):971-976. doi: 10.13201/j.issn.2096-7993.2022.12.017.
[Article in Chinese]

Abstract

At present, the main treatment for vestibular schwannomas is surgery. Considering the risk of multiple complications from surgery and the subjective and objective conditions of patients, a non-surgical treatment modality, namely stereotactic radiotherapy, has gradually been included in the treatment of vestibular schwannomas. Studies have shown that Gamma Knife therapy has a more prominent therapeutic effect on smaller tumors and can alleviate facial nerve disorders caused by space occupying of tumor mass. Cyberknife not only has a better effect on tumor control, but also has an ideal retention rate for patients' auditory function. Proton beam therapy has also been gradually applied to the treatment of vestibular schwannomas, but the effect of treatment remains to be further studied. Drug therapy includes a variety of target inhibitors and anti-angiogenic drugs. At present, drug treatment focuses more on preclinical research. This article reviews the clinical research of various radiotherapy and the progress of drug treatment.

摘要: 目前听神经瘤的治疗方式以手术治疗为主,考虑到手术带来的多种并发症风险和患者的主/客观条件,非手术治疗中的立体定位放射治疗逐渐成为听神经瘤治疗的一部分。研究表明,伽马刀治疗对较小的肿瘤治疗效果较突出,并可缓解因肿瘤占位带来的面神经及听神经疾病。赛博刀不仅对肿瘤的控制效果较好,而且患者的听功能保留率也较为理想。质子束疗法也逐渐应用于听神经瘤的治疗,但还需进一步研究。药物治疗(包括多种靶点抑制剂与抗血管生成药物)目前多聚焦于临床前研究。本文对多种放射治疗临床研究与药物治疗进展进行综述。.

Keywords: auditory function; drug therapy; radiation therapy; vestibular schwannomas.

Publication types

  • Review
  • English Abstract

MeSH terms

  • Facial Nerve Diseases*
  • Hearing / physiology
  • Humans
  • Neuroma, Acoustic* / pathology
  • Neuroma, Acoustic* / radiotherapy
  • Radiosurgery* / adverse effects
  • Retrospective Studies
  • Treatment Outcome